PEAK6 Investments’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-905
Closed -$18K 5018
2020
Q4
$18K Sell
905
-203
-18% -$4.25K ﹤0.01% 4343
2020
Q3
$27K Sell
1,108
-959
-46% -$22.4K ﹤0.01% 4101
2020
Q2
$49K Sell
2,067
-3,911
-65% -$90.6K ﹤0.01% 4015
2020
Q1
$103K Sell
5,978
-8,585
-59% -$157K ﹤0.01% 3287
2019
Q4
$257K Sell
14,563
-8,680
-37% -$147K ﹤0.01% 2403
2019
Q3
$411K Buy
23,243
+10,591
+84% +$214K ﹤0.01% 2422
2019
Q2
$270K Buy
+12,652
New +$265K ﹤0.01% 2676

Other funds holding EXEL

PEAK6 Investments's EXEL Position: Q1 2021 in Review

PEAK6 Investments sold out of Exelixis (EXEL) in Q1 2021, closing a stake of 905 shares — an estimated $18K sold.

PEAK6 Investments first reported a position in EXEL in Q2 2019 and held it in 7 quarters. The position peaked at $411K in Q3 2019. 347 funds tracked by Wall St. Rank hold EXEL as of Q1 2021.

  • PEAK6 Investments reported no remaining Exelixis position as of Q1 2021 after selling out during the quarter.
  • PEAK6 Investments sold 905 Exelixis shares in Q1 2021, an estimated $18K.
  • PEAK6 Investments first reported a position in Exelixis in Q2 2019 and held it in 7 quarters.
  • PEAK6 Investments's Exelixis position peaked at $411K in Q3 2019.
  • 347 funds tracked by Wall St. Rank held Exelixis as of Q1 2021.

Based on PEAK6 Investments's 13F filing for Q1 2021, filed 14 May 2021.